Lashyra Cotton
Vascular & Interventional Radiology · Cleveland, MSNPI 1205404282
Payments from drug & device makers
What this record shows
Abbott accounts for 65.8% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $2,632 and has fallen 81.1% since, to $498 in 2025.
Across 128 payments — averaging $48.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Novartis$473
- Cordis US CORP.$282
- Merck$204
- Alnylam Pharmaceuticals Inc.$204
- Terumo Medical Corporation$151
- plus $826 from 15 others
What the payments were for
- Travel & lodging$3,00948%
- Food & beverage$3,24452%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 32 | $4,113 |
| Novartis | 22 | $473 |
| Cordis US CORP. | 8 | $282 |
| Merck | 10 | $204 |
| Alnylam Pharmaceuticals Inc. | 5 | $204 |
| Terumo Medical Corporation | 9 | $151 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $137 |
| AstraZeneca | 5 | $110 |
| Biotronik Inc. | 3 | $96 |
| Novo Nordisk | 3 | $68 |
| Johnson & Johnson | 4 | $60 |
| BD | 3 | $56 |
| Cardiovascular Systems Inc. | 3 | $52 |
| Bayer | 3 | $51 |
| Boehringer Ingelheim | 2 | $41 |
| Bridgebio Pharma, Inc. | 2 | $37 |
| Pfizer | 2 | $36 |
| Boston Scientific | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $19 |
| Medtronic | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few vascular & interventional radiology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 31 | $27,807 |
| XareltoRivaroxaban | 32 | $23,346 |
| EliquisApixaban | 20 | $17,282 |
| JardianceEmpagliflozin | 13 | $11,286 |
| ClopidogrelClopidogrel Bisulfate | 83 | $749 |
| Hydralazine Hcl | 44 | $404 |
| Cilostazol | 27 | $370 |
| Rosuvastatin Calcium | 20 | $278 |
| Losartan Potassium | 29 | $273 |
| Furosemide | 55 | $265 |
| Bumetanide | 11 | $231 |
| Metoprolol Succinate | 31 | $213 |
| Carvedilol | 37 | $213 |
| Ezetimibe | 12 | $196 |
| Pravastatin Sodium | 26 | $195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $473 | $27,80731 claims |
| Johnson & JohnsonXarelto | $60 | $23,34632 claims |
| PfizerEliquis | $36 | $17,28220 claims |
| Boehringer IngelheimJardiance | $41 | $11,28613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular & interventional radiology providers in Mississippion file to place this against a meaningful peer group, so we don't.
Other vascular & interventional radiology in Cleveland
- Samuel PutnamSouthaven$109K
- Matthew HyattJackson$16K
- Ajinkya DesaiJackson$10K
- Dustin ReedJackson$6K
- James ThomassonJackson$5K
- Garth CampbellJackson$4K
- Kathryn ParvinJackson$3K
- Amanda JohnsonCalhoun City$2K
- Patrick SewellCanton$1K
- Vipin PatelFlowood$438
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.